NCT03792776

Brief Summary

Comparing the effect of different methods of endotracheal tube cuff inflation on the occurrence of a postoperative sore throat and cough (Air vs Lidocaine 1% vs Lidocaine 2%).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 3, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

January 15, 2019

Status Verified

January 1, 2019

Enrollment Period

3 months

First QC Date

December 22, 2018

Last Update Submit

January 11, 2019

Conditions

Keywords

Lidocaine 1%Lidocaine 2%Endotracheal tube cuffCuff inflationPostoperative sore throatPostoperative coughGeneral anesthesiaEndotracheal intubation

Outcome Measures

Primary Outcomes (8)

  • Sore throat intensity 0

    Throat pain evaluation using the visual analog scale of pain (range from 0 cm (no pain) to 10 cm (very intense pain))

    hour 0 after extubation

  • Sore throat intensity 2

    Throat pain evaluation using the visual analog scale of pain (range from 0 cm (no pain) to 10 cm (very intense pain))

    at 2 hours after extubation

  • Sore throat intensity 6

    Throat pain evaluation using the visual analog scale of pain (range from 0 cm (no pain) to 10 cm (very intense pain))

    at 6 hours after extubation

  • Sore throat intensity 24

    Throat pain evaluation using the visual analog scale of pain (range: from 0 cm (no pain) to 10 cm (very intense pain))

    at 24 hours after extubation

  • Cough intensity 0

    Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))

    hour 0 after extubation

  • Cough intensity 2

    Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))

    at 2 hours after extubation

  • Cough intensity 6

    Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))

    at 6 hours after extubation

  • Cough intensity 24

    Cough intensity evaluation using the visual analog scale of cough (range from 0 cm (no cough) to 10 cm (very severe cough))

    at 24 hours after extubation

Study Arms (3)

Air

ACTIVE COMPARATOR

Endotracheal tube cuff inflation with air

Other: cuff inflation with airOther: Induction of anesthesiaOther: Maintenance of anesthesiaOther: Endotracheal intubationOther: Systematic post-operative analgesia

Lidocaine 1%

EXPERIMENTAL

Endotracheal tube cuff inflation with Lidocaine 1%

Drug: cuff inflation with lidocaine 1%Other: Induction of anesthesiaOther: Maintenance of anesthesiaOther: Endotracheal intubationOther: Systematic post-operative analgesia

Lidocaine 2%

EXPERIMENTAL

Endotracheal tube cuff inflation with Lidocaine 2%

Drug: cuff inflation with lidocaine 2%Other: Induction of anesthesiaOther: Maintenance of anesthesiaOther: Endotracheal intubationOther: Systematic post-operative analgesia

Interventions

Endotracheal tube cuff inflation with air

Air

Endotracheal tube cuff inflation with lidocaine 1%

Lidocaine 1%

Endotracheal tube cuff inflation with lidocaine 2%

Lidocaine 2%

The induction of anesthesia will be made following a preoxygenation with a facial mask with 100% Oxygen. It consists on the intravenous injection of Sufentanil 5 mcg or Fentanyl 50mcg, Lidocaine 1mg/Kg, Propofol 2.5mg/kg, Rocuronium 0.6mg/kg or Cisatracurium 0.15mg/kg.

AirLidocaine 1%Lidocaine 2%

Maintenance of anesthesia will be done by sevoflurane + nitrous oxide, and reinjections of morphinomimetics and curare will be made as needed (the total doses will be noted at the end of the intervention).

AirLidocaine 1%Lidocaine 2%

The intubation is made by a N° 7.5 tube in men and a N° 7 tube in women. Cuff inflation will be done upon placement of the endotracheal tube. The cuff's pressure will be monitored at several intervals of the intervention and kept \< or = 20 centimeter of water (cmH2O).

AirLidocaine 1%Lidocaine 2%

All patients will receive Paracetamol every 6 hours for the first 24 hours after the end of surgery.

AirLidocaine 1%Lidocaine 2%

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years old
  • American Society of Anesthesiologists classification (ASA) category 1 or 2
  • High pressure, low volume endotracheal tube - (Lo-pro)

You may not qualify if:

  • Ear nose and throat and cranial surgery
  • Ear nose and throat pathologies
  • Asthma and bronchial hyperreactivity
  • Chronic cough
  • Diabetes
  • Cognitive disorders
  • Swallowing disorders
  • Corticotherapy during the last week
  • Allergy to lidocaine
  • Urgent surgery
  • Nasogastric, oro-gastric
  • Ventral position
  • More than 2 intubation attempts
  • Continuous intravenous infusion of lidocaine intraoperatively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

AirIntubation, Intratracheal

Intervention Hierarchy (Ancestors)

AtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public HealthAirway ManagementTherapeuticsIntubationInvestigative Techniques

Study Officials

  • Hicham Jabbour, MD

    Saint JU

    STUDY DIRECTOR

Central Study Contacts

Ogarite P Habib, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 22, 2018

First Posted

January 3, 2019

Study Start

January 1, 2019

Primary Completion

April 1, 2019

Study Completion

October 1, 2020

Last Updated

January 15, 2019

Record last verified: 2019-01